When researching treatment options for short stature, many parents encounter confusing terminology. Understanding the difference between growth hormone vs growth hormone releasing hormone is essential when evaluating safe and evidence-based care for children.
Although the names sound similar, these two hormones serve very different roles in the body.
What Is Growth Hormone (GH)?
Growth hormone (GH), also called somatotropin, is a hormone produced by the pituitary gland. It is directly responsible for:
-
Linear height growth
-
Bone development
-
Muscle growth
-
Metabolic regulation
-
Stimulation of IGF-1 production in the liver
Growth hormone is released in pulses, primarily during deep sleep.
In the United States, synthetic recombinant growth hormone therapy is regulated by the U.S. Food and Drug Administration and approved for specific pediatric diagnoses such as:
-
Growth Hormone Deficiency (GHD)
-
Turner Syndrome
-
Prader-Willi Syndrome
-
Chronic Kidney Disease
-
Small for Gestational Age without catch-up growth
-
Idiopathic Short Stature (under defined criteria)
When a child has confirmed GHD, recombinant GH is the standard medical treatment.
What Is Growth Hormone Releasing Hormone (GHRH)?
Growth hormone releasing hormone (GHRH) is produced by the hypothalamus — a region of the brain that regulates hormone signaling.
Its role is to:
-
Stimulate the pituitary gland
-
Trigger the release of growth hormone
In simple terms:
GHRH tells the pituitary to release GH.
GH is the hormone that actually causes growth.
Growth Hormone vs Growth Hormone Releasing Hormone: Key Differences
1. Location of Production
-
GHRH: Produced in the hypothalamus
-
GH: Produced in the pituitary gland
2. Function
-
GHRH: Sends the signal
-
GH: Carries out the growth effects
3. Clinical Use
-
GH: FDA-approved for pediatric growth disorders
-
GHRH analogs: Limited pediatric approval and less commonly used
Why This Distinction Matters for Treatment
If a child has:
-
Pituitary dysfunction → Direct GH replacement may be needed
-
Hypothalamic signaling issues → In theory, GHRH could stimulate GH release
However, in clinical pediatric practice, recombinant growth hormone remains the primary and most studied therapy for confirmed deficiency.
Most GHRH-based therapies are either investigational, approved for limited adult indications, or used less frequently in children.
When Is Evaluation Necessary?
Parents should consider a growth evaluation if their child:
-
Falls below the 3rd percentile for height
-
Shows slowed growth velocity
-
Has delayed puberty
-
Demonstrates delayed bone age
Proper evaluation includes:
-
Growth chart analysis
-
IGF-1 lab testing
-
Bone age imaging
-
Growth hormone stimulation testing when indicated
Distinguishing between signaling issues (GHRH) and actual hormone deficiency (GH) requires professional assessment.
The Bottom Line
The difference between growth hormone vs growth hormone releasing hormone lies in signaling versus action. GHRH stimulates the release of growth hormone, while GH directly drives height and development.
For children with true growth hormone deficiency, direct GH therapy remains the gold standard due to its safety data and regulatory approval.
At HGH for Children, we provide comprehensive growth evaluations to determine the root cause of delayed growth and guide families through safe, evidence-based treatment options.
To learn more or schedule a consultation, visit:
https://www.HGHforChildren.com
